NCT06248580 Find HDV and Determine Its Status in Turkey
| NCT ID | NCT06248580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yaşar Bayındır, MD |
| Condition | Chronic Hepatitis D Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2024-03-11 |
| Primary Completion | 2025-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2024-03-11 with a primary completion date of 2025-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
Eligibility Criteria
Inclusion Criteria: * Adults (Age≥18) * Being HBsAg positive for at least six months * Being a citizen of the Republic of Türkiye Exclusion Criteria: * There are no exclusion criteria in this study.
Contact & Investigator
Mustafa Kemal Çelen, MD
PRINCIPAL INVESTIGATOR
Dicle University, Medical Faculty, Department of Infectious Diseases
Frequently Asked Questions
Who can join the NCT06248580 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Hepatitis D Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06248580 currently recruiting?
Yes, NCT06248580 is actively recruiting participants. Contact the research team at yasar.bayindir@guven.com.tr for enrollment information.
Where is the NCT06248580 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye), Diyarbakır, Turkey (Türkiye).
Who is sponsoring the NCT06248580 clinical trial?
NCT06248580 is sponsored by Yaşar Bayındır, MD. The principal investigator is Mustafa Kemal Çelen, MD at Dicle University, Medical Faculty, Department of Infectious Diseases. The trial plans to enroll 20,000 participants.